Gene · 7292
Papers4,164
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,164
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity. | Bioact Mater | 2024 | 37790917 | PubTator, text mining | PubMed |
| Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease Exhibits Activation of T Helper 1 and OX40 Cytokines. | J Invest Dermatol | 2024 | 37742913 | PubTator, text mining | PubMed |
| Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy. | Bioact Mater | 2024 | 37701452 | PubTator, text mining | PubMed |
| Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma. | Genes Dis | 2024 | 37692499 | PubTator, text mining | PubMed |
| CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer. | Biomol Biomed | 2024 | 37597212 | PubTator, text mining | PubMed |
| DisP-seq reveals the genome-wide functional organization of DNA-associated disordered proteins. | Nat Biotechnol | 2024 | 37037903 | PubTator, text mining | PubMed |
| Role of sirtuins in attenuating plaque vulnerability in atherosclerosis. | Mol Cell Biochem | 2024 | 36952068 | PubTator, text mining | PubMed |
| Biological Activity of Mouse OX40L-Igg Purified With Two Novel Resins. | Int J Mol Cell Med | 2023 | 39006201 | PubTator, text mining | PubMed |
| Virus-infected mast cells activate virus-specific CD8+ T cells. | Scand J Immunol | 2023 | 38441354 | PubTator, text mining | PubMed |
| Intratumoral microbiota: implications for cancer onset, progression, and therapy. | Front Immunol | 2023 | 38292482 | PubTator, text mining | PubMed |
| Oncolytic vaccinia virus and cancer immunotherapy. | Front Immunol | 2023 | 38283361 | PubTator, text mining | PubMed |
| Characterization of CD4+ and CD8+ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing. | Front Immunol | 2023 | 38283342 | PubTator, text mining | PubMed |
| Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy. | Front Immunol | 2023 | 38274827 | PubTator, text mining | PubMed |
| Transcriptional profiling specifies the pathogen-specific human host response to infectious keratitis. | Front Cell Infect Microbiol | 2023 | 38274739 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Identification of the shared genetic architecture underlying seven autoimmune diseases with GWAS summary statistics. | Front Immunol | 2023 | 38259487 | PubTator, text mining | PubMed |
| Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity. | Front Pharmacol | 2023 | 38259298 | PubTator, text mining | PubMed |
| Age-Related Changes in Serum N-Glycome in Men and Women-Clusters Associated with Comorbidity. | Biomolecules | 2023 | 38254617 | PubTator, text mining | PubMed |
| Spatial profiling of the placental chorioamniotic membranes reveals upregulation of immune checkpoint proteins during Group B Streptococcus infection in a nonhuman primate model. | Front Cell Infect Microbiol | 2023 | 38239507 | PubTator, text mining | PubMed |
| Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift. | Front Immunol | 2023 | 38239354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7292/papers?page=15